Literature DB >> 25126046

Clinical presentations of coenzyme q10 deficiency syndrome.

Catarina M Quinzii1, Valentina Emmanuele1, Michio Hirano1.   

Abstract

Coenzyme Q10 (CoQ10) deficiency is a clinically and genetically heterogeneous syndrome which has been associated with 5 major clinical phenotypes: (1) encephalomyopathy, (2) severe infantile multisystemic disease, (3) nephropathy, (4) cerebellar ataxia, and (5) isolated myopathy. Of these phenotypes, cerebellar ataxia and syndromic or isolated nephrotic syndrome are the most common. CoQ10 deficiency predominantly presents in childhood. To date, causative mutations have been identified in a small proportion of patients, making it difficult to identify a phenotype-genotype correlation. Identification of CoQ10 deficiency is important because the disease, in particular muscle symptoms and nephropathy, frequently responds to CoQ10 supplementation.

Entities:  

Keywords:  Cerebellar ataxia; Coenzyme Q10 deficiency; Encephalomyopathy; Steroid-resistant nephrotic syndrome

Year:  2014        PMID: 25126046      PMCID: PMC4112523          DOI: 10.1159/000360490

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  47 in total

1.  A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency.

Authors:  E Boitier; F Degoul; I Desguerre; C Charpentier; D François; G Ponsot; M Diry; P Rustin; C Marsac
Journal:  J Neurol Sci       Date:  1998       Impact factor: 3.181

2.  Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations.

Authors:  Luis Carlos López; Markus Schuelke; Catarina M Quinzii; Tomotake Kanki; Richard J T Rodenburg; Ali Naini; Salvatore Dimauro; Michio Hirano
Journal:  Am J Hum Genet       Date:  2006-10-27       Impact factor: 11.025

Review 3.  Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10).

Authors:  Rita Horvath
Journal:  J Inherit Metab Dis       Date:  2012-01-10       Impact factor: 4.982

4.  Ataxia with oculomotor apraxia type1 (AOA1): novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients.

Authors:  Barbara Castellotti; Caterina Mariotti; Marco Rimoldi; Roberto Fancellu; Massimo Plumari; Sara Caimi; Graziella Uziel; Nardo Nardocci; Isabella Moroni; Giovanna Zorzi; Davide Pareyson; Daniela Di Bella; Stefano Di Donato; Franco Taroni; Cinzia Gellera
Journal:  Neurogenetics       Date:  2011-04-05       Impact factor: 2.660

5.  Cerebellar ataxia with coenzyme Q10 deficiency: diagnosis and follow-up after coenzyme Q10 supplementation.

Authors:  Rafael Artuch; Gloria Brea-Calvo; Paz Briones; Asunción Aracil; Marta Galván; Carmen Espinós; Jordi Corral; Victor Volpini; Antonia Ribes; Antoni L Andreu; Francesc Palau; José A Sánchez-Alcázar; Plácido Navas; Mercè Pineda
Journal:  J Neurol Sci       Date:  2006-05-03       Impact factor: 3.181

6.  Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency.

Authors:  M Gironi; C Lamperti; R Nemni; M Moggio; G Comi; F R Guerini; P Ferrante; N Canal; A Naini; N Bresolin; S DiMauro
Journal:  Neurology       Date:  2004-03-09       Impact factor: 9.910

7.  COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement.

Authors:  Francesca Diomedi-Camassei; Silvia Di Giandomenico; Filippo M Santorelli; Gianluca Caridi; Fiorella Piemonte; Giovanni Montini; Gian Marco Ghiggeri; Luisa Murer; Laura Barisoni; Anna Pastore; Andrea Onetti Muda; Maria Luisa Valente; Enrico Bertini; Francesco Emma
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

8.  Clinical and genetic analysis of lipid storage myopathies.

Authors:  Aya Ohkuma; Satoru Noguchi; Hideo Sugie; May Christine V Malicdan; Tokiko Fukuda; Kunio Shimazu; Luis Carlos López; Michio Hirano; Yukiko K Hayashi; Ikuya Nonaka; Ichizo Nishino
Journal:  Muscle Nerve       Date:  2009-03       Impact factor: 3.217

9.  CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures.

Authors:  Julie Mollet; Agnès Delahodde; Valérie Serre; Dominique Chretien; Dimitri Schlemmer; Anne Lombes; Nathalie Boddaert; Isabelle Desguerre; Pascale de Lonlay; Hélène Ogier de Baulny; Arnold Munnich; Agnès Rötig
Journal:  Am J Hum Genet       Date:  2008-03       Impact factor: 11.025

10.  Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency.

Authors:  S Di Giovanni; M Mirabella; A Spinazzola; P Crociani; G Silvestri; A Broccolini; P Tonali; S Di Mauro; S Servidei
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

View more
  18 in total

1.  Primary Coenzyme Q deficiency Due to Novel ADCK3 Variants, Studies in Fibroblasts and Review of Literature.

Authors:  Adel Shalata; Michael Edery; Clair Habib; Jacob Genizi; Mohammad Mahroum; Lama Khalaily; Nurit Assaf; Idan Segal; Hoda Abed El Rahim; Hana Shapira; Danielle Urian; Shay Tzur; Liza Douiev; Ann Saada
Journal:  Neurochem Res       Date:  2019-04-09       Impact factor: 3.996

2.  Chromatin-remodeling SWI/SNF complex regulates coenzyme Q6 synthesis and a metabolic shift to respiration in yeast.

Authors:  Agape M Awad; Srivats Venkataramanan; Anish Nag; Anoop Raj Galivanche; Michelle C Bradley; Lauren T Neves; Stephen Douglass; Catherine F Clarke; Tracy L Johnson
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

Review 3.  Emerging therapies for mitochondrial diseases.

Authors:  Michio Hirano; Valentina Emmanuele; Catarina M Quinzii
Journal:  Essays Biochem       Date:  2018-07-20       Impact factor: 8.000

4.  A novel inborn error of the coenzyme Q10 biosynthesis pathway: cerebellar ataxia and static encephalomyopathy due to COQ5 C-methyltransferase deficiency.

Authors:  May Christine V Malicdan; Thierry Vilboux; Bruria Ben-Zeev; Jennifer Guo; Aviva Eliyahu; Ben Pode-Shakked; Amir Dori; Sravan Kakani; Settara C Chandrasekharappa; Carlos R Ferreira; Natalia Shelestovich; Dina Marek-Yagel; Hadass Pri-Chen; Ilan Blatt; John E Niederhuber; Langping He; Camilo Toro; Robert W Taylor; John Deeken; Tal Yardeni; Douglas C Wallace; William A Gahl; Yair Anikster
Journal:  Hum Mutat       Date:  2017-11-08       Impact factor: 4.878

5.  Fatal neonatal encephalopathy and lactic acidosis caused by a homozygous loss-of-function variant in COQ9.

Authors:  Katharina Danhauser; Diran Herebian; Tobias B Haack; Richard J Rodenburg; Tim M Strom; Thomas Meitinger; Dirk Klee; Ertan Mayatepek; Holger Prokisch; Felix Distelmaier
Journal:  Eur J Hum Genet       Date:  2015-06-17       Impact factor: 4.246

Review 6.  Neuromitochondrial Disorders : Genomic Basis and an Algorithmic Approach to Imaging Diagnostics.

Authors:  Santhakumar Senthilvelan; Sabarish S Sekar; Chandrasekharan Kesavadas; Bejoy Thomas
Journal:  Clin Neuroradiol       Date:  2021-06-09       Impact factor: 3.649

7.  Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology.

Authors:  Annalisa Marcuzzi; Elisa Piscianz; Marina Zweyer; Roberta Bortul; Claudia Loganes; Martina Girardelli; Gabriele Baj; Lorenzo Monasta; Claudio Celeghini
Journal:  Int J Mol Sci       Date:  2016-03-11       Impact factor: 5.923

8.  Cerebellar ataxia and severe muscle CoQ10 deficiency in a patient with a novel mutation in ADCK3.

Authors:  E Barca; O Musumeci; F Montagnese; S Marino; F Granata; D Nunnari; L Peverelli; S DiMauro; C M Quinzii; A Toscano
Journal:  Clin Genet       Date:  2016-02-16       Impact factor: 4.438

9.  COQ4 mutations cause a broad spectrum of mitochondrial disorders associated with CoQ10 deficiency.

Authors:  Gloria Brea-Calvo; Tobias B Haack; Daniela Karall; Akira Ohtake; Federica Invernizzi; Rosalba Carrozzo; Laura Kremer; Sabrina Dusi; Christine Fauth; Sabine Scholl-Bürgi; Elisabeth Graf; Uwe Ahting; Nicoletta Resta; Nicola Laforgia; Daniela Verrigni; Yasushi Okazaki; Masakazu Kohda; Diego Martinelli; Peter Freisinger; Tim M Strom; Thomas Meitinger; Costanza Lamperti; Atilano Lacson; Placido Navas; Johannes A Mayr; Enrico Bertini; Kei Murayama; Massimo Zeviani; Holger Prokisch; Daniele Ghezzi
Journal:  Am J Hum Genet       Date:  2015-02-05       Impact factor: 11.025

Review 10.  Mitochondrial Disorders.

Authors:  Thomas Klopstock; Claudia Priglinger; Ali Yilmaz; Cornelia Kornblum; Felix Distelmaier; Holger Prokisch
Journal:  Dtsch Arztebl Int       Date:  2021-11-05       Impact factor: 8.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.